Measurements and main results -Mean (SD) administration times for the NHP, HPPQ, SIP, and HAD were 7'9 (3.5), 10-5 (4.3), 21-0 (9.8), and 5-5 (2.8) minutes respectively. On average, the test-retest reliability was good, with Spearman correlations ranging from 0-31 to 0*95. In spite of the limited size of the study, all instruments were able to show differences between the study groups. For instance, median SIP total scores for myocardial infarction and stroke patients were 12-4 (interquartile range 7.0-19
(J7 Epidemiol Community Health 1995;49:513-517) Measurement of disease outcome is an important issue in medical research, especially in treatment trials. In general, this assessment can be applied at several levels of increasing complexity, as follows: (1) biological process, (2) impairments (of separate functions), (3) disability, (4) handicap (in which social roles are included), and (5) quality of life.'2 Across the spectrum from disease process to quality of life, the measures become applicable to more than one disease. They usually also become less sensitive and less objective but closer to fulfilment of chosen roles and to well being, and therefore more relevant from the patient's point of view.3 Quality of life has rarely been measured in controlled trials of patients with cardiovascular disease, although the importance of this measure is widely recognised. Several instruments for measuring quality of life have been developed, but their applicability to these specific groups of patients has hardly been tested. 8 For our feasibility study we selected multidimensional instruments, for which there is wide experience of use. According to previous recommendations, the criteria used for the selection were concept, origin, format, content, scoring, validity, reliability, and responsiveness.9 0 Two general purpose profiles designed for use in general populations were selected -the Nottingham health profile (NHP) and the sickness impact profile (SIP)."-'4 Both profiles have been applied in patient studies. [15] [16] [17] We also selected a measure specific to heart disease that had been developed in The Netherlands -the heart patients psychological questionnaire (HPPQ) -because of positive experience reported with this questionnaire in patients with heart disease in The Netherlands.'8`'9 Since anxiety and depression are reported in both categories of patients and may influence their quality of life,2024 the hospital anxiety and depression scale (HAD), derived from clinical practice and with a reported practicality of use, was included as an indicator of the presence of anxiety and or depression. [25] [26] The primary objective of the present study was to test the selected instruments for their feasibility in two groups of patients -one with a history of stroke in the previous five years and the other with a history of myocardial infarction (MI) in the previous five years. We studied assessment time and test-retest reliability. In addition, we examined whether, in spite of the limited size of the study, NHP and SIP as general purpose profiles could distinguish between patient groups and control groups. Median values for SIP total score, psychosocial and physical sum scores in the different study groups are presented in table 4, with corresponding p values. In tables 5, 6 , and 7 the results are presented for different dimensions of NHP, HPPQ, and HAD. Most instruments were able to detect differences between the study groups. Statistically significant differences were found for SIP (total score) in the comparison between MI patients and controls (table 4). For separate dimensions of SIP, statistically significant differences were found for emotional behaviour, for both post stroke patients and post MI patients in comparison with controls; for household management in Table 7 After careful selection, the next step is to test the feasibility and reliability of the selected instruments for the study population. The present study was designed to assess whether some of the instruments used would turn out to be less suitable than others and should be excluded from a planned main study with a larger number of participants. Use of all instruments was feasible in the study groups as judged from an acceptable administration time and from the subjects' reactions. Since the time elapsed since MI or stroke was at least six months, we expected the condition of the patients to remain relatively stable and the correlations between assessments with an interval of 14 days to be high. Test-retest reliability was satisfactory. In spite of the relatively limited number of patients included, the instruments were able to detect differences between the study groups, some of them statistically significant. These results seem promising with regard to the sensitivity of the instruments. That the average age of the stroke patients was six years lower than that of controls may have contributed to the relatively low scores on SIP, but did not prevent the two HAD scores from being significantly higher than in controls.
Patients and methods
The implications of some of the findings in the present study groups can be fully addressed only when based on a larger number of subjects. Given the performance of the instruments in the present study, however, we believe that they deserve to be considered by other investigators in similar research.
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